Showing results (181-190 of 379) with videos related to

Sort By:
Pageof 38
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 15, 2012
Prediction of kidney-related outcomes in patients with type 2 diabetesMeg J Jardine, Jun Hata, Mark Woodward, et al.
BMJ Open|February 21, 2019
Randomised controlled trial of the impact of haemodiafiltration on uraemic neuropathy: FINESSE study protocolBrendan Smyth, Arun V Krishnan, Martin Gallagher, et al.
Diabetologia|March 15, 2019
Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS ProgramDavid R Matthews, Qiang Li, Vlado Perkovic, et al.
The New England Journal of Medicine|May 24, 2024
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 DiabetesVlado Perkovic, Katherine R Tuttle, Peter Rossing, et al.
Diabetes, Obesity & Metabolism|May 29, 2024
Machine learning for prediction of chronic kidney disease progression: Validation of the Klinrisk model in the CANVAS Program and CREDENCE trialNavdeep Tangri, Thomas W Ferguson, Ryan J Bamforth, et al.
Journal of the American Heart Association|January 30, 2020
Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-AnalysisClare Arnott, Qiang Li, Amy Kang, et al.
Diabetes Care|October 4, 2013
The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide to predict cardiovascular events and death in patients with type 2 diabetesGraham S Hillis, Paul Welsh, John Chalmers, et al.
Nephrology (Carlton, Vic.)|February 7, 2019
Quality of life in caregivers compared with dialysis recipients: The Co-ACTIVE sub-study of the ACTIVE dialysis trialNicholas A Gray, Li Zuo, Daqing Hong, et al.
Hypertension (Dallas, Tex. : 1979)|July 15, 2009
Blood pressure is a major risk factor for renal death: an analysis of 560 352 participants from the Asia-Pacific regionConall M O'Seaghdha, Vlado Perkovic, Tai Hing Lam, et al.
Diabetes Care|September 22, 2022
Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVASAkihiko Koshino, Meir Schechter, Taha Sen, et al.
Pageof 38